According to the industry analysis report titled ‘Global Antibiotics Market - Analysis By Drug Class (Beta-Lactams, Cephalosporins, Lipopeptide, Others), Mechanism, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of COVID-19 (2021-2026)’ available with MarketStudyReport, global antibiotics market generated revenues worth USD 46.66 billion in 2020 and is estimated to expand substantially during 2021-2026.

The growing geriatric population, rising technical advancements, surging investments in R&D activities, and increasing prevalence of infectious diseases are some of the major factors driving the growth of the global antibiotics market.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4383307/   

The growing trend of excessive use of antibiotics is putting forth the risk of increasing antimicrobial resistance which will make the current antibiotics ineffective against disease-causing bacteria. Therefore, growing focus on improving global clinical research efforts for new antibiotics are adding traction to the overall market size.

Numerous patients are getting prescribed antibiotics for their COVID-19 treatment which in turn is impacting the demand significantly and leading to supply chain shortages.

The global antibiotics marketplace is fragmented on the basis of drug class type, mechanism type, and regional contribution.

Based on drug class type, the market is further segmented into lipopeptide, cephalosporins, beta-lactams (penicillin), and others. Moving on to mechanism type, the market is divided into protein synthesis, cell wall synthesis, DNA synthesis, and others.

The geographical analysis of this business space extends to the Latin America, Middle East & Africa, Asia-Pacific, North America, and Europe, with major emphasis on countries such as China, India, Japan, Spain, France, the U.K., Germany, the U.S., Italy, and Canada. The report cites that North America currently accounts for the largest market share and will expand consistently in the forthcoming years.

The leading companies operating in the global antibiotics market space include Deinove SAS, Pfizer Inc., Novartis AG, Roche Holding AG, Johnson & Johnson, Bayer Group, GlaxoSmithKline plc, Eli Lily and Company, Amgen Inc., and Merck KGaA.